U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07287020) titled 'PRICE vs PEACE and LOVE in Adolescent Lateral Ankle Sprain Rehabilitation' on Dec. 03. Bri... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284199) titled 'CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in No... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285733) titled 'Multimodal Neuromonitoring at the ICU' on Nov. 19. Brief Summary: Neurocritical care has b... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284628) titled 'Vortioxetine for Newly Diagnosed Glioblastoma' on Sept. 28. Brief Summary: There is a very... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284875) titled 'Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weig... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285850) titled 'The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advance... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286071) titled 'Safety and Efficacy of Traditional Versus Suction Ureteral Access Sheath in Retrograde Intr... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284381) titled 'A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulatio... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285252) titled 'Evaluating Non-Invasive Haptics During Extreme Exercise' on Dec. 03. Brief Summary: This s... Read More
U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284134) titled 'JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positi... Read More